A fire broke out at the Serum Institute in India, the world’s largest vaccine maker, while the production of coronavirus vaccines was remain unaffected.
The Serum Institute is developing the Covishield Coronavirus vaccine at the Serum Institute, which will be sold to India and other countries.
A local TV channel released a video of a fire at a company based in the western part of Pune, India, in which smoke could be seen rising.
Sources at the Serum Institute told the news agency that “this will not affect the development of the COVID-19 vaccine” and that the fire had started at a new plant under construction.
A fire station official said six to seven fire trucks arrived at the scene, covering an area of more than 100 acres.
According to the report, 3 people have been rescued while the number of trapped people has not been revealed yet.
The fire brigade told NDTV that “the smoke has stopped work and the fire is being contained.”
The report added that the fire-hit complex was located a few minutes away from the Corona vaccine plant.
According to Indian TV, 8 or 9 buildings are under construction in the complex to expand the manufacture of medicines.
Adar Poonawalla, head of the Serum Institute, said in a Tweet, “I would like to reassure all governments & the public that there would be no loss of COVISHIELD production due to multiple production buildings that I had kept in reserve to deal with such contingencies at Serum InstIndia. Thank you very much
Pune City Police & Fire Department.”
I would like to reassure all governments & the public that there would be no loss of #COVISHIELD production due to multiple production buildings that I had kept in reserve to deal with such contingencies at @SerumInstIndia. Thank you very much @PuneCityPolice & Fire Department
— Adar Poonawalla (@adarpoonawalla) January 21, 2021
The Serum Institute, founded by Cyrus Poonawalla in 1966, produces the largest number of vaccines in the world in terms of numbers, with a dose of 15 billion vaccines a year even before the Coronavirus pandemic.
The Serum Institute develops vaccines for other infectious diseases, including polio, diphtheria, tetanus, hepatitis B and rubella, which are exported to 170 countries around the world.
The company has invested billions of dollars in recent years and is expanding its main Pune campus.
The Indian government this month approved the Covishield and Bharat Biotech vaccine, developed by the Serum Institute.
India launched the world’s largest vaccine delivery process on January 16 and aims to provide vaccines to 300 million people by July, both Covishield and Covaxin.
According to the report, many other countries around the world are also waiting for the Serum Institute vaccine.
India sent the first consignment of vaccines to Bhutan and the Maldives yesterday, followed by 2 million doses for Bangladesh and 1 million doses for Nepal.
In the next phase, India plans to supply 200 million tonnes of food to its neighbors in South Asia, Latin America, Africa and Central Asia.
The Serum Institute is also preparing to provide 200 million doses of Covaxin for the World Health Organization’s vaccine delivery project to poor countries.
Brazil said last week that its plane was coming to India for 2 million meals, but President Jair Bolsonaro said the flight was postponed due to political pressure in India.
Adar Poonawalla, head of the Serum Institute, said the vaccine would be delivered to Brazil in two weeks.